654055-09-1

Basic information

• Product Name: 3-(4-cyano-phenyl)-2-(2,2,2-trifluoro-acetylamino)-propionic acid
• Synonyms: 3-(4-cyano-phenyl)-2-(2,2,2-trifluoro-acetylamino)-propionic acid
• CAS NO: 654055-09-1
• Molecular Weight: 286.21
• Mol File: 654055-09-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-(4-cyano-phenyl)-2-(2,2,2-trifluoro-acetylamino)-propionic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-cyano-phenyl)-2-(2,2,2-trifluoro-acetylamino)-propionic acid(654055-09-1)
• EPA Substance Registry System: 3-(4-cyano-phenyl)-2-(2,2,2-trifluoro-acetylamino)-propionic acid(654055-09-1)

Safety Data

• Hazardous Substances Data: 654055-09-1(Hazardous Substances Data)

Upstream product

• 18910-26-4 2-amino-3-(4-cyano-phenyl)-propionic acid 
• 407-25-0 trifluoroacetic anhydride 

Downstream Products

• 777044-08-3 N-{1-[3-(4-carbamimidoyl-benzyl)-1-methyl-2-oxo-1,2-dihydro-quinoxalin-6-yl]-cyclopropyl}-N-cyclopentyl-malonamic acid ethyl ester 
• 246542-35-8 N-{1-[3-(4-cyano-benzyl)-1-methyl-2-oxo-1,2-dihydro-quinoxalin-6-yl]-cyclopropyl}-N-cyclopentyl-malonamic acid ethyl ester 
• 592465-38-8 4-{4-methyl-3-oxo-7-[1-(pyrrolidine-1-carbonyl)-cyclopropyl]-3,4-dihydro-quinoxalin-2-ylmethyl}-benzonitrile 
• 246542-34-7 4-{[6-(1-cyclopentylamino-cyclopropyl)-1-methyl-2-oxo-1,2-dihydroquinoxalin-3-yl]-methyl}-benzonitrile 
• 246542-32-5 4-{[6-(1-(N-tert-butyloxycarbonylamino)-cyclopropyl)-1-methyl-2-oxo-1,2-dihydroquinoxalin-3-yl)-methyl]-benzonitrile 
• 236418-15-8 4-[(6-(1-carboxy-cyclopropan-1-yl)-1-methyl-2-oxo-1,2-dihydroquinoxalin-3-yl)-methyl]-benzonitrile 
• 246542-33-6 4-{[6-(1-amino-cyclopropyl)-1-methyl-2-oxo-1,2-dihydroquinoxalin-3-yl)-methyl]-benzonitrile 
• 43229-87-4 3-(4-cyano-phenyl)-2-oxo-propionic acid 

Relevant articles and documents

Heterocyclic thrombin inhibitors. Part 2: Quinoxalinone derivatives as novel, potent antithrombotic agents

Quinoxalinone derivatives as prototypes of dual thrombin and factor Xa inhibitors have been discovered. Nanomolar inhibition of both coagulation enzymes resulted in very potent antithrombotic activity in vitro.